Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.

Mowla A, Kamal H, Lail NS, Vaughn C, Shirani P, Mehla S, Rajabzadeh-Oghaz H, Deline C, Ching M, Crumlish A, Sawyer RN.

J Stroke Cerebrovasc Dis. 2017 Apr 21. pii: S1052-3057(17)30126-X. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.021. [Epub ahead of print]

PMID:
28438515
2.

Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.

Mowla A, Doyle J, Lail NS, Rajabzadeh-Oghaz H, Deline C, Shirani P, Ching M, Crumlish A, Steck DA, Janicke D, Levy EI, Sawyer RN.

J Neurol Sci. 2017 May 15;376:102-105. doi: 10.1016/j.jns.2017.03.003. Epub 2017 Mar 3.

PMID:
28431590
3.

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators..

N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930. Epub 2016 Feb 17.

4.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators..

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

PMID:
26618534
5.

Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.

AbdelRazek MA, Mowla A, Hojnacki D, Zimmer W, Elsadek R, Abdelhamid N, Elsadek L, Farooq S, Kamal H, Crumlish A, Shirani P, Ching M, Sawyer R.

Cerebrovasc Dis. 2015;40(5-6):201-4. doi: 10.1159/000439141. Epub 2015 Sep 25.

PMID:
26402147
6.

Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?

Mowla A, Singh K, Mehla S, Ahmed MK, Shirani P, Kamal H, Krishna C, Sawyer RN Jr, Ching M, Siddiqui AH, Levy EI, Snyder KV, Crumlish A, Hopkins LN.

Int J Stroke. 2015 Oct;10 Suppl A100:113-8. doi: 10.1111/ijs.12616. Epub 2015 Sep 17.

PMID:
26377963
7.

Safety of intravenous thrombolysis for acute ischemic stroke in patients with preexisting intracranial neoplasms: a case series.

Singh K, Mowla A, Mehla S, Ahmed MK, Shirani P, Zimmer WE, Sawyer RN, Kamal H, Crumlish A, Ching M.

Int J Stroke. 2015 Apr;10(3):E29-30. doi: 10.1111/ijs.12455. No abstract available.

PMID:
25777837
8.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators..

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

9.

SOLITAIREā„¢ with the intention for thrombectomy (SWIFT) trial: design of a randomized, controlled, multicenter study comparing the SOLITAIREā„¢ Flow Restoration device and the MERCI Retriever in acute ischaemic stroke.

Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira R, Clark W, Budzik R, Zaidat OO; SWIFT Trialists..

Int J Stroke. 2014 Jul;9(5):658-68. doi: 10.1111/j.1747-4949.2012.00856.x. Epub 2012 Nov 6.

PMID:
23130938
10.

Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators..

N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. Erratum in: N Engl J Med. 2012 Jul 5;367(1):93.

11.

Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.

Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS Investigators..

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):357-68. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.001.

12.
13.

Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials.

Shi ZS, Loh Y, Walker G, Duckwiler GR; MERCI and Multi-MERCI Investigators..

Stroke. 2010 May;41(5):953-60. doi: 10.1161/STROKEAHA.109.571943. Epub 2010 Apr 8.

14.

First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).

Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, Hopkins LN, Mocco J.

Stroke. 2009 Nov;40(11):3552-6. doi: 10.1161/STROKEAHA.109.561274. Epub 2009 Aug 20.

Supplemental Content

Loading ...
Support Center